Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Researchers examined associations between air pollution and the progression of chronic lung diseases toward lung multimorbidity and mortality.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
A deep learning model called Sybil can predict a person’s risk of lung cancer using a single low-dose CT scan, a study suggests.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Krazati is a highly selective and potent oral small molecule inhibitor of KRASG12C.
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Researchers sought to quantitatively and qualitatively characterize symptoms experienced by patients with malignant pleural mesothelioma.